CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)-Reference-Cited by-同舟云学术

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)

Published:2017-07-11 Issue:6 Volume:65 Page:959-966
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Trickey Adam¹,May Margaret T¹,Schommers Philipp²,Tate Jan³,Ingle Suzanne M¹,Guest Jodie L⁴,Gill M John⁵,Zangerle Robert⁶,Saag Mike⁷,Reiss Peter⁸,Monforte Antonella d’Arminio⁹,Johnson Margaret¹⁰,Lima Viviane D¹¹,Sterling Tim R¹²,Cavassini Matthias¹³,Wittkop Linda¹⁴,Costagliola Dominique¹⁵,Sterne Jonathan A C¹,Boulle Andrew,Stephan Christoph,Miro Jose M,Cavassini Matthias,Chêne Geneviève,Costagliola Dominique,Dabis François,Monforte Antonella D’Arminio,del Amo Julia,Van Sighem Ard,Vehreschild Jorg Janne,Gill John,Guest Jodie,Haerry David Hans-Ulrich,Hogg Robert,Justice Amy,Shepherd Leah,Obel Niels,Crane Heidi M,Smith Colette,Reiss Peter,Saag Michael,Sterling Tim,Teira Ramon,Williams Matthew,Zangerle Robert,Sterne Jonathan,May Margaret,Ingle Suzanne,Trickey Adam,

Affiliation:

1. School of Social and Community Medicine, University of Bristol, United Kingdom;

2. Department I for Internal Medicine, University Hospital of Cologne, Germany;

3. Yale University School of Medicine, West Haven, Connecticut;

4. HIV Atlanta Veterans Affairs Cohort Study, Atlanta Veterans Affairs Medical Center, Decatur, Georgia;

5. Division of Infectious Diseases, University of Calgary, Alberta, Canada;

6. Innsbruck Medical University, Austria;

7. Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham;

8. Stichting HIV Monitoring, and Division of Infectious Diseases and Department of Global Health, Academic Medical Center, University of Amsterdam, and Amsterdam Institute for Global Health and Development, The Netherlands;

9. Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy;

10. Department of HIV Medicine, Royal Free London NHS Foundation Trust, United Kingdom;

11. British Columbia Centre for Excellence in HIV/AIDS, and Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, Canada;

12. Vanderbilt University School of Medicine, Nashville, Tennessee;

13. Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Switzerland; and

14. INSERM, Unit of Epidemiology and Biostatistics, Bordeaux, and

15. Sorbonne Universités, INSERM, UPMC Université Paris 06, Institut Pierre Louis d’épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France

Funder

National Institute for Health Research

Institut National de la Santé et de la Recherche Médicale

Swiss National Science Foundation

European Commission

National Institutes of Health

National Institute on Alcohol Abuse and Alcoholism

Canadian Institutes of Health Research

Michael Smith Foundation for Health Research

Publisher

Oxford University Press (OUP)

Subject